FDA Inspection 1118971 — Lovelace Biomedical Research Institute
The FDA completed an inspection of Lovelace Biomedical Research Institute on January 31, 2020 in Albuquerque, NM. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 31, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Albuquerque, NM (United States)
Additional Details
Animal Rule-Specific Study